Cor.4U human iPS cell-derived cardiomyocytes on QPatch and Qube
Two new application reports with Cor.4U® human iPS cell-derived cardiomyocytes from Ncardia on QPatch and Qube.
The hiPSC – CM provide new strategies to assess cardiotoxicity in vitro and different technologies are available to assess compound effects on cardiomyocytes.
Here we demonstrate
- High throughput and high fidelity voltage and current clamp recordings
- Presence of INa, ICa and IKr
- Paced and spontaneous action potentials
- We also show that the use of fluoride in the internal solution resulted in lower ICa and shortened action potential durations on QPatch.
See the report for QPatch (Link) and for Qube (Link)
Also, you are welcome to check out our other publications on stem cells here